Statins do not alter the incidence of mesothelioma in asbestos exposed mice or humans.
Mesothelioma is principally caused by asbestos and may be preventable because there is a long latent period between exposure and disease development. The most at-risk are a relatively well-defined population who were exposed as a consequence of their occupations. Although preventative agents investi...
Main Authors: | Cleo Robinson, Helman Alfonso, Samantha Woo, Amy Walsh, Nola Olsen, Arthur W Musk, Bruce W S Robinson, Anna K Nowak, Richard A Lake |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4122392?pdf=render |
Similar Items
-
Asbestos Exposure and the Mesothelioma Incidence in Poland
by: Małgorzata Krówczyńska, et al.
Published: (2018-08-01) -
Mesothelioma and asbestos on Tyneside
by: Ashcroft, T.
Published: (1971) -
Non-Hodgkin Lymphoma and Pleural Mesothelioma in a Person Exposed to Asbestos
by: Claudio BIANCHI, et al.
Published: (2018-05-01) -
Zeolites ameliorate asbestos toxicity in a transgenic model of malignant mesothelioma
by: Xiyong Fan, et al.
Published: (2019-09-01) -
Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
by: Jenette Creaney, et al.
Published: (2014-01-01)